The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
113158766 11315876 6 F 20150615 20160722 20150728 20160728 EXP JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-046728 BRISTOL MYERS SQUIBB 70.00 YR F Y 0.00000 20160728 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
113158766 11315876 1 PS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, Q3WK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION Q3W
113158766 11315876 2 SS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, UNK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION
113158766 11315876 3 SS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, UNK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION
113158766 11315876 4 SS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, UNK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION
113158766 11315876 5 SS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, UNK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION
113158766 11315876 6 SS NIVOLUMAB NIVOLUMAB 1 Intravenous drip 2 MG/KG, UNK 2 MG/KG Y 125554 2 MG/KG SOLUTION FOR INJECTION
113158766 11315876 7 SS AZULFIDINE SULFASALAZINE 1 Oral 500 MG, BID U 0 500 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
113158766 11315876 1 Malignant melanoma
113158766 11315876 7 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
113158766 11315876 HO
113158766 11315876 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
113158766 11315876 Herpes zoster
113158766 11315876 Inappropriate schedule of drug administration
113158766 11315876 Musculoskeletal pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
113158766 11315876 1 20150610 20150610 0
113158766 11315876 2 20150701 20150701 0
113158766 11315876 3 20150803 20150803 0
113158766 11315876 4 20151109 20151109 0
113158766 11315876 5 20151207 20151207 0
113158766 11315876 6 20160113 20160113 0
113158766 11315876 7 200705 0